This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 Jul;12(7):3198-3199.

doi: 10.1016/j.apsb.2022.04.004. Epub 2022 Apr 8.

Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212]

Yunhao Wu¹, Xiu Yu¹, Yuwei Wang¹, Yalin Huang¹, Jiahui Tang¹, Shuaishuai Gong¹, Siyu Jiang¹, Yuanli Xia¹, Fang Li¹, Boyang Yu¹, Yuanyuan Zhang¹, Junping Kou¹

Affiliations

Affiliation

¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

PMID: 35865100
PMCID: PMC9293698
DOI: 10.1016/j.apsb.2022.04.004

Published Erratum

Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212]

Yunhao Wu et al. Acta Pharm Sin B. 2022 Jul.

. 2022 Jul;12(7):3198-3199.

doi: 10.1016/j.apsb.2022.04.004. Epub 2022 Apr 8.

Authors

Yunhao Wu¹, Xiu Yu¹, Yuwei Wang¹, Yalin Huang¹, Jiahui Tang¹, Shuaishuai Gong¹, Siyu Jiang¹, Yuanli Xia¹, Fang Li¹, Boyang Yu¹, Yuanyuan Zhang¹, Junping Kou¹

Affiliation

¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

PMID: 35865100
PMCID: PMC9293698
DOI: 10.1016/j.apsb.2022.04.004

Abstract

[This corrects the article DOI: 10.1016/j.apsb.2021.09.017.].

© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Erratum for

Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling.
Wu Y, Yu X, Wang Y, Huang Y, Tang J, Gong S, Jiang S, Xia Y, Li F, Yu B, Zhang Y, Kou J. Wu Y, et al. Acta Pharm Sin B. 2022 Mar;12(3):1198-1212. doi: 10.1016/j.apsb.2021.09.017. Epub 2021 Sep 22. Acta Pharm Sin B. 2022. PMID: 35530141 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources